HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pulmonary toxicity syndrome following CDEP (cyclophosphamide, dexamethasone, etoposide, cisplatin) chemotherapy.

Abstract
We report on three patients with multiple myeloma who developed drug-induced pneumonitis 1-2(1/2) months following maintenance (post autologous transplantation) chemotherapy with CDEP (cyclophosphamide, dexamethasone, etoposide, cisplatin) and 6-20 months after exposure to carmustine (BCNU) 300 mg/m(2), used in combination with melphalan 140 mg/m(2), as pre-transplant conditioning regimen. All patients had either a proven (two) or suspected (one) fungal pneumonia and were treated with liposomal amphotericin B. Dyspnea, fever and cough were the prominent clinical symptoms, while air-space disease with ground glass appearance was seen radiographically. Histologic features typical for drug-induced lung injury were detected. All patients had a dramatic, clinical and radiographic response to a brief course of corticosteroids. Although CDEP-induced pneumonitis appears to be a rare complication, its early recognition and prompt treatment, as well as its possible association with preceding fungal infection may have important clinical implications.
AuthorsA Fassas, I Gojo, A Rapoport, M Cottler-Fox, B Meisenberg, J C Papadimitriou, G Tricot
JournalBone marrow transplantation (Bone Marrow Transplant) Vol. 28 Issue 4 Pg. 399-403 (Aug 2001) ISSN: 0268-3369 [Print] England
PMID11571514 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Etoposide
  • Dexamethasone
  • Cyclophosphamide
  • Cisplatin
  • Carmustine
Topics
  • Aged
  • Antineoplastic Combined Chemotherapy Protocols (adverse effects, therapeutic use)
  • Carmustine (administration & dosage, adverse effects)
  • Cisplatin (administration & dosage, adverse effects)
  • Combined Modality Therapy (adverse effects)
  • Cyclophosphamide (administration & dosage, adverse effects)
  • Dexamethasone (administration & dosage, adverse effects)
  • Etoposide (administration & dosage, adverse effects)
  • Female
  • Hematopoietic Stem Cell Transplantation (adverse effects)
  • Humans
  • Lung Diseases, Fungal (chemically induced, pathology)
  • Male
  • Middle Aged
  • Multiple Myeloma (complications, drug therapy, therapy)
  • Pneumonia, Pneumocystis (chemically induced, pathology)
  • Syndrome
  • Transplantation Conditioning (adverse effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: